谷歌浏览器插件
订阅小程序
在清言上使用

Supplementary Tables S1-S3 from A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance

openalex(2023)

引用 0|浏览1
关键词
PD-1 and PD-L1,Cancer Immunoediting
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要